Literature DB >> 8804026

Immunocytochemically detectable metallothionein is expressed by astrocytes in the ischaemic human brain.

J W Neal1, S K Singhrao, B Jasani, G R Newman.   

Abstract

The metallothioneins in vitro are both effective free radical and transitional metal ion scavengers. For this reason we investigated the expression of this protein in the normal CNS and after ischaemia using a monoclonal anti-metallothionein antibody to metallothionein isoforms I and II. Using immunohistochemistry and confocal laser scanning microscopy, we found anti-GFAP and anti-metallothionein were co-localized in astrocytes at the edges of infarcts. Energy dispersive X-ray microanalysis demonstrated high levels of copper and iron in the metallothionein positive reactive astrocytes. On the basis of the in vitro properties of these proteins, the functional importance of metallothionein in reactive astrocytes could be as a free radical scavenger and metal ion chelator.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8804026

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  12 in total

1.  CNS wound healing is severely depressed in metallothionein I- and II-deficient mice.

Authors:  M Penkowa; J Carrasco; M Giralt; T Moos; J Hidalgo
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

Review 2.  Metallothionein in the central nervous system: Roles in protection, regeneration and cognition.

Authors:  Adrian K West; Juan Hidalgo; Donnie Eddins; Edward D Levin; Michael Aschner
Journal:  Neurotoxicology       Date:  2008-01-19       Impact factor: 4.294

Review 3.  Metallothionein and brain inflammation.

Authors:  Yasmina Manso; Paul A Adlard; Javier Carrasco; Milan Vašák; Juan Hidalgo
Journal:  J Biol Inorg Chem       Date:  2011-06-16       Impact factor: 3.358

4.  Drug resistance-associated factors in primary and secondary glioblastomas and their precursor tumors.

Authors:  D S Tews; A Nissen; C Külgen; A K Gaumann
Journal:  J Neurooncol       Date:  2000-12       Impact factor: 4.130

5.  Metallothioneins and brain injury: What transgenic mice tell us.

Authors:  Juan Hidalgo
Journal:  Environ Health Prev Med       Date:  2004-05       Impact factor: 3.674

6.  Hemichorea-hemiballism syndrome: A look through susceptibility weighted imaging.

Authors:  Puneet Mittal
Journal:  Ann Indian Acad Neurol       Date:  2011-04       Impact factor: 1.383

7.  Assessment of the Therapeutic Potential of Metallothionein-II Application in Focal Cerebral Ischemia In Vitro and In Vivo.

Authors:  Abass Eidizadeh; Manuel Khajehalichalehshtari; Dorette Freyer; George Trendelenburg
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

Review 8.  The interrelationship between cerebral ischemic stroke and glioma: a comprehensive study of recent reports.

Authors:  Mrinal K Ghosh; Dipankar Chakraborty; Sibani Sarkar; Arijit Bhowmik; Malini Basu
Journal:  Signal Transduct Target Ther       Date:  2019-10-12

9.  Susceptibility weighted imaging as a useful imaging adjunct in hemichorea hyperglycaemia.

Authors:  Ferry Dharsono; Andrew Thompson; Jolandi van Heerden; Andrew Cheung
Journal:  Case Rep Radiol       Date:  2013-05-23

Review 10.  Serotonin 1A Receptors on Astrocytes as a Potential Target for the Treatment of Parkinson's Disease.

Authors:  Ikuko Miyazaki; Masato Asanuma
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.